{"pmid":32348791,"title":"Clinical characteristics of COVID-19 patients with abnormal liver tests.","text":["Clinical characteristics of COVID-19 patients with abnormal liver tests.","J Hepatol","Chen, Peng","Zhou, Benhong","32348791"],"journal":"J Hepatol","authors":["Chen, Peng","Zhou, Benhong"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348791","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jhep.2020.04.028","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1665441658313900032,"score":8.599203,"similar":[{"pmid":32298767,"title":"Characteristics of Liver Tests in COVID-19 Patients.","text":["Characteristics of Liver Tests in COVID-19 Patients.","BACKGROUND & AIMS: Recent data on the coronavirus disease 2019 (COVID-19) outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has begun to shine light on the impact of the disease on the liver. But no studies to date have systematically described liver test abnormalities in patients with COVID-19. We evaluated the clinical characteristics of COVID-19 in patients with abnormal liver tests. METHODS: Clinical records and laboratory results were obtained from 417 laboratory-confirmed COVID-19 patients who were admitted to the only referral hospital in Shenzhen, China from January 11 to February 21, 2020 and followed up to March 7, 2020. Information of clinical features of patients with abnormal liver tests were collected for analysis. RESULTS: Of 417 patients with COVID-19, 318 (76.3%) had abnormal liver test results and 90 (21.5%) had liver injury during hospitalization. The presence of abnormal liver tests became more pronounced during hospitalization within 2 weeks, with 49 (23.4%), 31 (14.8%), 24 (11.5%) and 51 (24.4%) patients raising liver enzyme levels to more than 3 times of upper limit units in alanine aminotransferase, aspartate aminotransferase, total bilirubin and gamma-glutamyl transferase, respectively. Patients with abnormal liver test of hepatocellular type or mixed type at admission had higher odds of progressing to severe disease (odds ratios (OR)=2.73, 95% confidence interval (CI) 1.19-6.3, and 4.44, 95% CI 1.93-10.23, respectively). The use of lopinavir/ritonavir was also found to lead to increased odds of liver injury (OR from 4.44 to 5.03, both P<0.01). CONCLUSION: Patients with abnormal liver tests had higher risks of progressing to severe disease. The detrimental effects on liver injury mainly related to certain medications used during hospitalization, should be monitored and evaluated frequently.","J Hepatol","Cai, Qingxian","Huang, Deliang","Yu, Hong","Zhu, Zhibin","Xia, Zhang","Su, Yinan","Li, Zhiwei","Zhou, Guangde","Gou, Jizhou","Qu, Jiuxin","Sun, Yan","Liu, Yingxia","He, Qing","Chen, Jun","Liu, Lei","Xu, Lin","32298767"],"abstract":["BACKGROUND & AIMS: Recent data on the coronavirus disease 2019 (COVID-19) outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has begun to shine light on the impact of the disease on the liver. But no studies to date have systematically described liver test abnormalities in patients with COVID-19. We evaluated the clinical characteristics of COVID-19 in patients with abnormal liver tests. METHODS: Clinical records and laboratory results were obtained from 417 laboratory-confirmed COVID-19 patients who were admitted to the only referral hospital in Shenzhen, China from January 11 to February 21, 2020 and followed up to March 7, 2020. Information of clinical features of patients with abnormal liver tests were collected for analysis. RESULTS: Of 417 patients with COVID-19, 318 (76.3%) had abnormal liver test results and 90 (21.5%) had liver injury during hospitalization. The presence of abnormal liver tests became more pronounced during hospitalization within 2 weeks, with 49 (23.4%), 31 (14.8%), 24 (11.5%) and 51 (24.4%) patients raising liver enzyme levels to more than 3 times of upper limit units in alanine aminotransferase, aspartate aminotransferase, total bilirubin and gamma-glutamyl transferase, respectively. Patients with abnormal liver test of hepatocellular type or mixed type at admission had higher odds of progressing to severe disease (odds ratios (OR)=2.73, 95% confidence interval (CI) 1.19-6.3, and 4.44, 95% CI 1.93-10.23, respectively). The use of lopinavir/ritonavir was also found to lead to increased odds of liver injury (OR from 4.44 to 5.03, both P<0.01). CONCLUSION: Patients with abnormal liver tests had higher risks of progressing to severe disease. The detrimental effects on liver injury mainly related to certain medications used during hospitalization, should be monitored and evaluated frequently."],"journal":"J Hepatol","authors":["Cai, Qingxian","Huang, Deliang","Yu, Hong","Zhu, Zhibin","Xia, Zhang","Su, Yinan","Li, Zhiwei","Zhou, Guangde","Gou, Jizhou","Qu, Jiuxin","Sun, Yan","Liu, Yingxia","He, Qing","Chen, Jun","Liu, Lei","Xu, Lin"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298767","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jhep.2020.04.006","keywords":["covid-19","liver tests","liver injury","sars-cov-2"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Shenzhen","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["lopinavir-ritonavir drug combination","Bilirubin"],"_version_":1664641388284739586,"score":83.21448},{"pmid":32205284,"title":"Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings.","text":["Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings.","PURPOSE: To investigate the epidemiological, clinical characteristics of COVID-19 patients with abnormal imaging findings. METHODS: Patients confirmed with SARS-CoV-2 infection of Zhejiang province from Jan 17 to Feb 8 underwent CT or x-ray were enrolled. Epidemiological, clinical data were analyzed between those with abnormal or normal imaging findings. RESULTS: Excluding 72 patients with normal images, 230 of 573 patients affected more than two lobes. The median radiograph score was 2.0 and there's negative correlation between the score and oxygenation index (rho=-0.657,P < 0.001). Patients with abnormal images were older (46.65 +/- 13.82), with higher rate of coexisting condition(28.8%), lower rate of exposure history and longer time between onset and confirmation(5d) than non-pneumonia patients(all P < 0.05). Higher rate of fever, cough, expectoration, and headache, lower lymphocytes, albumin, serum sodium levels and higher total bilirubin, creatine kinase, lactate dehydrogenase and C-reactive protein levels and lower oxygenation index were observed in pneumonia patients (all P < 0.05). Muscle ache, shortness of breath, nausea and vomiting, lower lymphocytes levels and higher serum creatinine and radiograph score at admission were predictive factors for severe/critical subtype. CONCLUSION: Patients with abnormal images have more obvious clinical manifestations and laboratory changes. Combing clinical features and radiograph score can effectively predict severe/critical type.","Int J Infect Dis","Zhang, Xiaoli","Cai, Huan","Hu, Jianhua","Lian, Jiangshan","Gu, Jueqing","Zhang, Shanyan","Ye, Chanyuan","Lu, Yingfeng","Jin, Ciliang","Yu, Guodong","Jia, Hongyu","Zhang, Yimin","Sheng, Jifang","Li, Lanjuan","Yang, Yida","32205284"],"abstract":["PURPOSE: To investigate the epidemiological, clinical characteristics of COVID-19 patients with abnormal imaging findings. METHODS: Patients confirmed with SARS-CoV-2 infection of Zhejiang province from Jan 17 to Feb 8 underwent CT or x-ray were enrolled. Epidemiological, clinical data were analyzed between those with abnormal or normal imaging findings. RESULTS: Excluding 72 patients with normal images, 230 of 573 patients affected more than two lobes. The median radiograph score was 2.0 and there's negative correlation between the score and oxygenation index (rho=-0.657,P < 0.001). Patients with abnormal images were older (46.65 +/- 13.82), with higher rate of coexisting condition(28.8%), lower rate of exposure history and longer time between onset and confirmation(5d) than non-pneumonia patients(all P < 0.05). Higher rate of fever, cough, expectoration, and headache, lower lymphocytes, albumin, serum sodium levels and higher total bilirubin, creatine kinase, lactate dehydrogenase and C-reactive protein levels and lower oxygenation index were observed in pneumonia patients (all P < 0.05). Muscle ache, shortness of breath, nausea and vomiting, lower lymphocytes levels and higher serum creatinine and radiograph score at admission were predictive factors for severe/critical subtype. CONCLUSION: Patients with abnormal images have more obvious clinical manifestations and laboratory changes. Combing clinical features and radiograph score can effectively predict severe/critical type."],"journal":"Int J Infect Dis","authors":["Zhang, Xiaoli","Cai, Huan","Hu, Jianhua","Lian, Jiangshan","Gu, Jueqing","Zhang, Shanyan","Ye, Chanyuan","Lu, Yingfeng","Jin, Ciliang","Yu, Guodong","Jia, Hongyu","Zhang, Yimin","Sheng, Jifang","Li, Lanjuan","Yang, Yida"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32205284","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.ijid.2020.03.040","keywords":["SRAS-CoV-2","clinical","epidemiological","imaging findings","predictive factors"],"source":"PubMed","locations":["Zhejiang"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism"],"weight":1,"e_drugs":["Creatinine","Bilirubin","Sodium"],"_version_":1663352133731221504,"score":70.11943},{"pmid":32339487,"title":"Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.","text":["Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.","BACKGROUND: In December 2019, coronavirus disease 2019 (COVID-19) was first found in Wuhan, China and soon was reported all around the world. METHODS: All confirmed cases with COVID-19 in Wenzhou from January 19 to February 20, 2020, were collected and analyzed. Of the 116 patients with COVID-19, 27 were diagnosed as severe cases. Among severe cases, 9 were treated in ICU. The data of blood routine examination were analyzed and compared among common patients (as common group), severe patients admitted to intensive care unit (as severe ICU group) and severe patients not admitted to ICU (as severe non-ICU group). The blood routine examination results were dynamically observed in the above groups after admission. RESULTS: Patients with COVID-19 have lower counts of leucocytes, lymphocytes, eosinophils, platelets, and hemoglobin, but have higher neutrophil-lymphocyte ratio (NLR) and monocyte-lymphocyte ratio (MLR), which were compared with controls (P<0.001). In severe ICU group, patients have the lowest count of lymphocytes, but the highest neutrophil count and NLR among the above three groups (all P values <0.05); NLR and MLR indicators were combined for diagnostic efficacy analysis of severe COVID-19, and its area under the curve reached 0.925. The odds ratio of the delay in days to the start of the increase of eosinophil count for predicting the outcome of patients with severe COVID-19 was 2.291 after age adjusted. CONCLUSIONS: Patients with COVID-19 have abnormal peripheral blood routine examination results. Dynamic surveillance of peripheral blood system especially eosinophils is helpful in the prediction of severe COVID-19 cases.","Clin Chim Acta","Sun, Suyu","Cai, Xuejiao","Wang, Huaguo","He, Guiqing","Lin, Yin","Lu, Bibi","Chen, Chaoyue","Pan, Yong","Hu, Xingzhong","32339487"],"abstract":["BACKGROUND: In December 2019, coronavirus disease 2019 (COVID-19) was first found in Wuhan, China and soon was reported all around the world. METHODS: All confirmed cases with COVID-19 in Wenzhou from January 19 to February 20, 2020, were collected and analyzed. Of the 116 patients with COVID-19, 27 were diagnosed as severe cases. Among severe cases, 9 were treated in ICU. The data of blood routine examination were analyzed and compared among common patients (as common group), severe patients admitted to intensive care unit (as severe ICU group) and severe patients not admitted to ICU (as severe non-ICU group). The blood routine examination results were dynamically observed in the above groups after admission. RESULTS: Patients with COVID-19 have lower counts of leucocytes, lymphocytes, eosinophils, platelets, and hemoglobin, but have higher neutrophil-lymphocyte ratio (NLR) and monocyte-lymphocyte ratio (MLR), which were compared with controls (P<0.001). In severe ICU group, patients have the lowest count of lymphocytes, but the highest neutrophil count and NLR among the above three groups (all P values <0.05); NLR and MLR indicators were combined for diagnostic efficacy analysis of severe COVID-19, and its area under the curve reached 0.925. The odds ratio of the delay in days to the start of the increase of eosinophil count for predicting the outcome of patients with severe COVID-19 was 2.291 after age adjusted. CONCLUSIONS: Patients with COVID-19 have abnormal peripheral blood routine examination results. Dynamic surveillance of peripheral blood system especially eosinophils is helpful in the prediction of severe COVID-19 cases."],"journal":"Clin Chim Acta","authors":["Sun, Suyu","Cai, Xuejiao","Wang, Huaguo","He, Guiqing","Lin, Yin","Lu, Bibi","Chen, Chaoyue","Pan, Yong","Hu, Xingzhong"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339487","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.cca.2020.04.024","keywords":["covid-19","lymphocyte","neutrophil-lymphocyte ratio","peripheral blood","eosinophils"],"locations":["Wuhan","China","Wenzhou","Wenzhou","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1665264685516062720,"score":68.743195},{"pmid":32274341,"pmcid":"PMC7132021","title":"Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.","text":["Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.","An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (2019 coronavirus disease, COVID-19) since December 2019, from Wuhan, China, has been posing a significant threat to global human health. The clinical features and outcomes of Chinese patients with COVID-19 have been widely reported. Increasing evidence has witnessed the frequent incident liver injury in COVID-19 patients, and it is often manifested as transient elevation of serum aminotransferases; however, the patients seldom have liver failure and obvious intrahepatic cholestasis, unless pre-existing advanced liver disease was present. The underlying mechanisms of liver injury in cases of COVID-19 might include psychological stress, systemic inflammation response, drug toxicity, and progression of pre-existing liver diseases. However, there is insufficient evidence for SARS-CoV-2 infected hepatocytes or virus-related liver injury in COVID-19 at present. The clinical, pathological and laboratory characteristics as well as underlying pathophysiology and etiology of liver injury in COVID-19 remain largely unclear. In this review, we highlight these important issues based on the recent developments in the field, for optimizing the management and treatment of liver injury in Chinese patients with COVID-19.","J Clin Transl Hepatol","Li, Jie","Fan, Jian-Gao","32274341"],"abstract":["An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (2019 coronavirus disease, COVID-19) since December 2019, from Wuhan, China, has been posing a significant threat to global human health. The clinical features and outcomes of Chinese patients with COVID-19 have been widely reported. Increasing evidence has witnessed the frequent incident liver injury in COVID-19 patients, and it is often manifested as transient elevation of serum aminotransferases; however, the patients seldom have liver failure and obvious intrahepatic cholestasis, unless pre-existing advanced liver disease was present. The underlying mechanisms of liver injury in cases of COVID-19 might include psychological stress, systemic inflammation response, drug toxicity, and progression of pre-existing liver diseases. However, there is insufficient evidence for SARS-CoV-2 infected hepatocytes or virus-related liver injury in COVID-19 at present. The clinical, pathological and laboratory characteristics as well as underlying pathophysiology and etiology of liver injury in COVID-19 remain largely unclear. In this review, we highlight these important issues based on the recent developments in the field, for optimizing the management and treatment of liver injury in Chinese patients with COVID-19."],"journal":"J Clin Transl Hepatol","authors":["Li, Jie","Fan, Jian-Gao"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32274341","week":"202015|Apr 06 - Apr 12","doi":"10.14218/JCTH.2020.00019","keywords":["covid-19","clinical characteristics","liver injury","mechanism","sars-cov-2"],"source":"PubMed","topics":["Treatment","Diagnosis","Mechanism"],"weight":1,"locations":["Wuhan","China","Chinese","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664637190066405376,"score":66.51975},{"pmid":32119647,"title":"Laboratory abnormalities in patients with COVID-2019 infection.","text":["Laboratory abnormalities in patients with COVID-2019 infection.","Clin Chem Lab Med","Lippi, Giuseppe","Plebani, Mario","32119647"],"journal":"Clin Chem Lab Med","authors":["Lippi, Giuseppe","Plebani, Mario"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32119647","week":"202010|Mar 02 - Mar 08","doi":"10.1515/cclm-2020-0198","keywords":["covid-19","coronavirus","laboratory medicine","laboratory tests","prognosis"],"source":"PubMed","topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1664640875039293441,"score":65.12008}]}